BIOS Capital Management, LP 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
BC BIOS Capital Management, LP | Institutional Filer | ▼ 36.01% | $52.9M | 6 |
Current Portfolio Holdings
Showing all 6 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | ACTU | Actuate Therapeutics Inc | Healthcare | 10.0M | $27.5M | 52.09% |
| 2 | IRD | Opus Genetics, Inc. | Healthcare | 3.7M | $16.8M | 31.70% |
| 3 | CGTX | Cognition Therapeutics, Inc. | Healthcare | 6.0M | $4.6M | 8.63% |
| 4 | RNTX | Rein Therapeutics Inc. | Healthcare | 2.0M | $2.6M | 4.87% |
| 5 | LTRN | Lantern Pharma Inc. | Healthcare | 864K | $1.2M | 2.24% |
| 6 | INAB | IN8bio, Inc. | Healthcare | 168K | $248K | 0.47% |
Showing 1 to 6 of 6 holdings